Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.
The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...
Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...
Volunteers in north Wales are among 25,000 people taking part in a global trial to find a vaccine against the symptoms of the ...
Moderna estimates that a norovirus vaccine has a total addressable market ... vaccine that’s taken as a pill, rather than an injection. It’s currently in early stage human testing of its ...
Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...
Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to ... assigned to receive a single intramuscular injection of mRNA-1403 or placebo. According to the Company ...